Paper · 3932050
Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
Agrawal NM and 4 others. Dig Dis Sci, 1985. Cited by 64 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1. Papers, record 3932050. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3932050
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Healing of benign gastric ulcer. A placebo-controlled comparison of two dosage regimens of misoprostol, a synthetic analog of prostaglandin E1.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Alprostadil | Major topic |
| Anti-Ulcer Agents | Major topic |
| Stomach Ulcer | Major topic |
| Adult | |
| Aged | |
| Clinical Trials as Topic | |
| Double-Blind Method | |
| Drug Administration Schedule | |
| Female | |
| Gastroscopy | |
| Humans | |
| Male | |
| Middle Aged | |
| Misoprostol | |
| Placebos | |
| Pyloric Antrum | |
| Random Allocation |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 334,336 | Cimetidine in patients with gastric ulcer: a multicentre controlled trial. | Br Med J | 1977 | https://conductscience.org/library/papers/334336 | PubMed |
| 2 | 620,911 | Cimetidine in the treatment of gastric ulcer: review and commentary. | Gastroenterology | 1978 | https://conductscience.org/library/papers/620911 | PubMed |
| 3 | 321,925 | Problems of interpretation in secondary prevention trials in coronary heart disease. | Med J Aust | 1977 | https://conductscience.org/library/papers/321925 | PubMed |
| 4 | 747,466 | Effect of SC-29333, an inhibitor of gastric secretion, on canine gastric mucosal blood flow and serum gastrin levels. | Arch Int Pharmacodyn Ther | 1978 | https://conductscience.org/library/papers/747466 | PubMed |
| 5 | 797,257 | SC-29333: a potent inhibitor of canin gastric secretion. | Am J Dig Dis | 1976 | https://conductscience.org/library/papers/797257 | PubMed |
| 6 | 340,332 | Cimetidine, antacid, and hospitalization in the treatment of benign gastric ulcer: a multicenter double blind study. | Gastroenterology | 1978 | https://conductscience.org/library/papers/340332 | PubMed |
| 7 | 7,027,858 | Peptic ulcer: new therapies, new diseases. | Ann Intern Med | 1981 | https://conductscience.org/library/papers/7027858 | PubMed |
| 8 | 849,813 | Gastric and duodenal ulcer healing under placebo treatment. | Gastroenterology | 1977 | https://conductscience.org/library/papers/849813 | PubMed |
| 9 | 174,967 | Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration. | Gastroenterology | 1976 | https://conductscience.org/library/papers/174967 | PubMed |
| 10 | 6,604,619 | Effect of synthetic prostaglandin E1 analog on aspirin-induced gastric bleeding and secretion. | Dig Dis Sci | 1983 | https://conductscience.org/library/papers/6604619 | PubMed |
1 to 10 of 18
See all 18 referencesCited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 64 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,545,918 | NSAID-induced injury of gastric epithelial cells is reversible: roles of mitochondria, AMP kinase, NGF, and PGE2. | Am J Physiol Gastrointest Liver Physiol | 2019 | https://conductscience.org/library/papers/31545918 | PubMed |
| 25,059,824 | Novel mechanisms and signaling pathways of esophageal ulcer healing: the role of prostaglandin EP2 receptors, cAMP, and pCREB. | Am J Physiol Gastrointest Liver Physiol | 2014 | https://conductscience.org/library/papers/25059824 | PubMed |
| 7,766,337 | A comparative overview of the adverse effects of antiulcer drugs. | Drug Saf | 1995 | https://conductscience.org/library/papers/7766337 | PubMed |
| 3,932,053 | Overview of clinical safety with misoprostol. | Dig Dis Sci | 1985 | https://conductscience.org/library/papers/3932053 | PubMed |
| 3,792,228 | Prostaglandins in peptic ulcer disease. An overview of current status and future directions. | Drugs | 1986 | https://conductscience.org/library/papers/3792228 | PubMed |
| 3,125,025 | Evaluation of antisecretory activity of misoprostol in duodenal ulcer patients using long-term intragastric pH monitoring. | Dig Dis Sci | 1988 | https://conductscience.org/library/papers/3125025 | PubMed |
| 3,102,205 | Misoprostol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of peptic ulcer disease. | Drugs | 1987 | https://conductscience.org/library/papers/3102205 | PubMed |
| 3,080,288 | Overview of misoprostol clinical experience. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/3080288 | PubMed |
| 3,080,283 | Effects of misoprostol on gastric acid and mucus secretion in man. | Dig Dis Sci | 1986 | https://conductscience.org/library/papers/3080283 | PubMed |
| 2,081,487 | Nonsteroidal anti-inflammatory drug therapy and gastric side effects. Does nabumetone provide a solution? | Drugs | 1990 | https://conductscience.org/library/papers/2081487 | PubMed |
1 to 10 of 12
See all 12 cited byGenes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/3932050
GET https://conductscience.org/api/papers/v1/3932050/authors